Sponsored Links
| Biota Obtains US$2.9m NIH Grant For The Development Of Novel Antibacterial |
 |
 |
 |
| Medical News - Immune System and Vaccines | |||
|
Biota Holdings Limited (ASX:BTA) advises that its wholly owned subsidiary, Biota Scientific Management Pty Ltd, has been awarded a grant to fund the preclinical development of a lead candidate for the treatment of Clostridium difficile (C. difficile). The first years payment is US$830,287 of a 5 year grant totalling US$2.9m... Read more: Immune System / Vaccines News From Medical News Today
|